Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Follow us on Twitter

  • National Cancer Institute is funding research on using programmable synthetic messenger RNA to treat two types of s… https://t.co/kYyOAY6MOf
    about 10 hours ago
  • New post on Science and Enterprise: NIH Funds Programmable mRNA to Treat Cancer https://t.co/DKptaY956d #Science #Business
    about 10 hours ago
  • Attn @ArcticFisheries .. Why Migraine Sufferers May Want to Eat More Fish https://t.co/3AaUvjuNqT
    about 13 hours ago
  • Drug maker Sanofi is purchasing biotechnology company Translate Bio, a developer of messenger RNA vaccines and ther… https://t.co/iJUJA00PmY
    about 1 day ago
  • New post on Science and Enterprise: Sanofi Acquires mRNA Developer in $3.2B Deal https://t.co/lRVt9pv3bq #Science #Business
    about 1 day ago

Please share Science & Enterprise

FDA Clears Stem Cell Trial for Multiple Sclerosis

neurons

The Food and Drug Administration has authorized a clinical trial of stem cells extracted and cultured from patients to treat their cases of multiple sclerosis. . . . → Read More: FDA Clears Stem Cell Trial for Multiple Sclerosis

Micro Brain Robot Granted Orphan Status

Brain tumor graphic

A tiny remote-controlled device that carries chemotherapy drugs to brain tumors received orphan drug status from the Food and Drug Administration. . . . → Read More: Micro Brain Robot Granted Orphan Status

FDA Okays Trial of Donated Stem Cells for Parkinson’s

Neurons

An organization studying stem cell therapies says it received FDA authorization for a clinical trial to test donated stem cells to treat Parkinson’s disease. . . . → Read More: FDA Okays Trial of Donated Stem Cells for Parkinson’s

FDA Okays Lower Dose, Injected Covid-19 Antibodies

Intradermal injection

The Food and Drug Administration updated its emergency authorization for a dual-antibody Covid-19 therapy to allow for a lower and injectable dose. . . . → Read More: FDA Okays Lower Dose, Injected Covid-19 Antibodies

Trial Shows Same High/Low Dose Aspirin Outcomes

White pills

Results from a large-scale clinical trial show almost the same health outcomes for patients prescribed high or low doses of aspirin to prevent heart disease. . . . → Read More: Trial Shows Same High/Low Dose Aspirin Outcomes

Lilly Asks FDA to Revoke Covid-19 Therapy Clearance

SARS-CoV-2 and cell

Drug maker Eli Lilly and Co. asked the Food and Drug Administration to revoke its authorization for bamlanivimab alone to treat for Covid-19 infections. . . . → Read More: Lilly Asks FDA to Revoke Covid-19 Therapy Clearance

NIH Trial Testing mRNA Vaccine Allergic Effects

Syringe

A clinical trial is underway testing for allergic reactions to Covid-19 vaccines using messenger RNA for invoking an immune response. . . . → Read More: NIH Trial Testing mRNA Vaccine Allergic Effects

Coupons, Vouchers Used for Few Prescription Drugs

Pills and dollar bill

An analysis of customer transactions shows discounts from suppliers are used for only a small fraction of prescription drugs on the market. . . . → Read More: Coupons, Vouchers Used for Few Prescription Drugs

FDA Authorizes Non-Prescription Covid-19 Test

Cue Covid-19 test

Food and Drug Administration granted an emergency authorization for a molecular test for SARS-CoV-2 viruses done at home without a prescription. . . . → Read More: FDA Authorizes Non-Prescription Covid-19 Test

NIH Assessing Home Covid-19 Diagnostic with App

QuickVue test package

A home Covid-19 test is being evaluated with a smartphone app, as part of an NIH program to quickly develop Covid-19 diagnostics for widespread use. . . . → Read More: NIH Assessing Home Covid-19 Diagnostic with App